Skip to main content
. 2007 Jul;9(3):314–318. doi: 10.1215/15228517-2007-002

Table 2.

Reported molecular genetic testing

By Tumor Type
Anaplastic oligodendroglioma 95%
 Obtain in 76%–100% of patients 75%
 Obtain in 51%–75% of patients 5%
 Obtain in 1%–50% of patients 15%
 Never obtain 5%
Mixed glioma (oligoastrocytoma) 92%
Anaplastic astrocytoma 33%
Low-grade oligodendroglioma 14%
Glioblastoma 7%
By Methodology
FISH 48%
LOH 29%
Both FISH and LOH 6%
Unsure/not answered 17%

Abbreviations: FISH, fluorescence in situ hybridization; LOH, loss of heterozygosity.